In 2014, the founders of Medical Marijuana Genetics started becoming aware of the therapeutic properties of the cannabis plant whilst desperately treating the symptoms of one of their mother’s late stage pancreatic cancer

Not long after her first dose of cannabis oil, her ability to move around relatively pain-free was hugely increased, enabling her to tend to her beloved garden in the weeks leading up to her death. The benefit that the cannabis oil had given her was clearly visible to those around her and awoke a passion and deep interest in the use of cannabis as a medicine.  Shortly after, the website www.medicalmarijuana.co.uk was born and a little later, a concept to source and sell seeds that could create cannabis plants with exciting therapeutic benefit, at the same time as raising awareness.

Through the organisation’s interaction with patients and cannabis communities worldwide, it became apparent very quickly that access to cannabis genetics high in any other cannabinoid than THC was severely limited.

As a result of this, Medical Marijuana Genetics was formed and commenced work with award winning breeders and caregivers, with the initial aim of creating a line of CBD dominant cannabis strains.

MMGenetics created Candida-CD1, a 20:1 CBD to THC strain, and a further line of CBD dominant cannabis strains, 5 of which are available now.

Testing the cannabinoid profiles of CD-1 revealed a CBD count of 20%. This percentage is the highest known count in a CBD-rich phenotype ever created in Europe.

Following the overwhelming success of their first grow, Medical Marijuana Genetics created a further 12 elite strains from Candida crosses, all of which have been genetically selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more.

Research continues at Medical Marijuana Genetics to create strains that contain beneficial amounts of other cannabinoids and terpenoids.   

For the time being, all of the strains available from Medical Marijuana Genetics are CBD dominant or CBD-rich (1:1) and all strains contain a minimum of 10 % CBD.

Medical Marijuana Genetics are one of a growing number of seedbanks that encourage customers, who are legally permitted to grow, to publish laboratory results of the cannabis they have produced.

FIND OUT MORE